Rationale for the use of very-low-dose combinations as first-line treatment of hypertension

Journal of Hypertension, Supplement

Volumn 19, Issue 4, 2001, Pages

  Waeber, Bernard ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Antihypertensive treatment; Blood pressure; Blood pressure control; Combination therapy; Compliance; Essential hypertension; Side effects

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE; DRUG COMBINATION; DRUG EFFECT; DRUG TOLERANCE; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; REVIEW;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; HUMANS; HYPERTENSION;

EID: 0035525107     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Murray CJ, Lopez AD. Evidence-based health policy - lessons from the Global Burden of Disease Study. Science 1996; 274:740-743.
2. Rosenblatt RA, Gherkin DC, Schneeweiss R, Hart LG. The content of ambulatory medical care in the United States. An interspecialty comparison. N Engl J Med 1983; 309:892-897.
3. 1999 World Health Organization-International Society of Hypertension. Guidelines for the Management of Hypertension. J Hypertens 1999; 17:151-183.
4. Marques-Vidal P, Tuomilehto J. Hypertension awareness, treatment and control in the community: is the 'rule of halves' still valid? J Hum Hypertens 1997; 11:213-223.
5. Alderman MH, Cohen H, Madhavan S. Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment. J Hypertens 1998; 16:761-769.